Biotechnology Get all the latest news from the field of biotechnology and its many applications, including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance, and market analysis.

Latest

Dec 05, 2016, 10:00 ET NMI® at 57.2%; November Non-Manufacturing ISM® Report On Business®; Business Activity Index at 61.7%; New Orders Index at 57.0%; Employment Index at 58.2%

Economic activity in the non-manufacturing sector grew in November for the 82nd consecutive month, say the nation's purchasing and supply...


Dec 05, 2016, 09:30 ET Cell Expansion Market Expected to Reach USD 18.74 Billion by 2022 - Scalar Market Research

According to the new market research report, "Cell Expansion Market, by Products (Consumable, Instruments, Automated Cell Expansion System),...


Dec 05, 2016, 09:25 ET Cognition Therapeutics to Highlight CT1812 Safety Data at the 9th Clinical Trials on Alzheimer's Disease (CTAD) Meeting

Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of therapeutics for the treatment of Alzheimer's...


Dec 05, 2016, 09:00 ET Cynosure Recognized Among Deloitte's 2016 Technology Fast 500™

Cynosure, Inc. (NASDAQ: CYNO) today announced it has been recognized as one of Deloitte's Technology Fast 500™, a ranking of the 500...


Dec 05, 2016, 09:00 ET BioPharmX Presents Research at Cell Biology 2016 Showing How Molecular Iodine Promotes Breast Health by Attacking Fibrocystic Breast Tissue

BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company developing products for the dermatology and women's health markets, will...


Dec 05, 2016, 08:55 ET AbbVie and Johns Hopkins to Collaborate on Cancer Research

AbbVie (NYSE: ABBV), a global biopharmaceutical company, and the Johns Hopkins University School of Medicine today announced that they signed a...


Dec 05, 2016, 08:50 ET AbbVie and Northwestern University's Lurie Cancer Center to collaborate on multi-year cancer research agreement

AbbVie (NYSE: ABBV), a global biopharmaceutical company, and Northwestern University today announced they signed a five-year collaboration...


Dec 05, 2016, 08:45 ET OstriGen Announces New Study Using Ostrich Antibodies in the Treatment of C. Difficile Infection

OstriGen Inc. is announcing a collaborative study with Beth Israel Deaconess Medical Center (BIDMC), on the use of orally administered ostrich...


Dec 05, 2016, 08:08 ET SystemOne and FIND announce collaboration for connected diagnostics

SystemOne (Boston, USA and Johannesburg, South Africa) and FIND (Geneva, Switzerland) have announced a collaboration to advance the connectivity of...


Dec 05, 2016, 08:00 ET Luminex wins R&D 100 Award for ARIES Systems

Luminex Corporation (NASDAQ: LMNX) today announced that the company was awarded the prestigious R&D 100 Award for its ARIES® Systems at the...


Dec 05, 2016, 08:00 ET Merck va fournir ses services Provantage® End-to-End à Acticor Biotech SAS

- Cette solution permet d'accélérer la mise au point et la production du fragment d'anticorps d'Acticor destiné au traitement de l'AVC ischémique...


Dec 05, 2016, 08:00 ET New Patent Infringement Lawsuit Filed Against Alcatel-Lucent Under Spherix Collaboration Agreement

Spherix Incorporated (Nasdaq: SPEX) an intellectual property development company committed to the fostering and monetization of intellectual...


Dec 05, 2016, 08:00 ET MabVax Therapeutics Expands Phase I Clinical Trial Investigation for Patients with Pancreatic Cancer to Include HonorHealth Research Institute

MabVax Therapeutics Holdings, Inc. (Nasdaq: MBVX), a clinical-stage oncology drug development company, announces the expansion of the Company's...


Dec 05, 2016, 08:00 ET MilliporeSigma to Provide Provantage® End-to-End Services to Acticor Biotech SAS

MilliporeSigma today announced that it will provide its Provantage® End-to-End services to Acticor Biotech SAS for accelerated development and...


Dec 05, 2016, 08:00 ET Merck vai prestar serviços completos Provantage® à Acticor Biotech SAS

A Merck, importante empresa de ciência e tecnologia, anunciou hoje que irá prestar serviços completos Provantage® à Acticor Biotech SAS para...


Dec 05, 2016, 08:00 ET Merck brindará servicios Provantage® integrales a Acticor Biotech SAS

Merck, compañía líder en ciencia y tecnología, anunció hoy que brindará sus servicios integrales Provantage® a Acticor Biotech SAS para el...


Dec 05, 2016, 08:00 ET DarioHealth Ends a Successful Diabetes Awareness Month

DarioHealth Corp. (NASDAQ: DRIO), a leader in digital health and mobile health solutions, announced today that user-engagement metrics were higher...


Dec 05, 2016, 08:00 ET Merck stellt Acticor Biotech SAS sein Provantage®-Serviceangebot zur Verfügung

- Beschleunigte Entwicklung und Herstellung des Antikörperfragments von Acticor für Hirninfarkt Merck, ein führendes Wissenschafts- und...


Dec 05, 2016, 08:00 ET Merck ofrece los servicios Provantage® End-to-End a Acticor Biotech SAS

- Acelera el desarrollo y fabricación del fragmento de anticuerpos de Acticor que trata el derrame isquémico Merck, una compañía de ciencia...


Dec 05, 2016, 07:10 ET Biotech Stocks on Investors' Radar -- Northwest Biotherapeutics, ACADIA Pharma, Acorda Therapeutics, and Ultragenyx Pharma

The U.S. Biotechnology industry is the leading Biotech player worldwide, with almost $108 billion of revenue and some $890 billion of total market...


Dec 05, 2016, 03:00 ET AOP Orphan and PharmaEssentia Announce Pivotal Phase III Results for Ropeginterferon Alfa-2b in Polycythemia Vera at the American Society of Hematology (ASH) Annual Meeting 2016

- At 12 months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete Hematologic Response...


Dec 05, 2016, 01:00 ET BrainStorm Announces NurOwn® Data to be Highlighted at the 27th International Symposium on ALS/MND

BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today data...


Dec 04, 2016, 19:30 ET Blueprint Medicines Announces Proof-of-Concept Data from Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Systemic Mastocytosis

Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically...


Dec 04, 2016, 19:30 ET Favorable Response Rates Suggest Promise of Ibrutinib (IMBRUVICA®) Combination Therapy in Two Common Types of Non-Hodgkin's Lymphoma

AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced encouraging efficacy and safety findings from two separate studies...


Dec 04, 2016, 13:01 ET Neue Daten zu Zebinix® (Eslicarbazepinacetat) 1 x täglich als Zusatztherapie zeigen gute Anfallskontrolle und Verträglichkeit bei Patienten mit Anfällen fokalen Ursprungs

NUR FÜR MEDIEN IN EMEA-LÄNDERN - NICHT FÜR MEDIEN IN SCHWEIZ/ÖSTERREICH/USA Zebinix® (Eslicarbazepinacetat) als Zusatztherapie bei Patienten...